-
As Moscow steps up attacks, Kyiv residents brace for harsh winter
-
Mexican cartels target Australia with their African meth
-
Markets mixed as China's Xi arrives for US talks
-
Rapper-turned-PM faces first big test after Nepal disaster
-
Archaeological 'breakthrough' could confirm origins of Paris
-
Meta launches camera-free AI glasses amid privacy pushback
-
Australian PM says OpenAI hacked government health website
-
Anthropic touts AI-led biology discovery
-
Rio breaks record for rainiest September amid powerful El Nino
-
Stocks fall on soaring bond yields, higher oil prices
-
Mandela Digital Extends Early Access Programme to 11 February 2027 Following Strong Response
-
ArcPoint Expands Globally with Institutional Intelligence Platform for Modern Investors
-
McDonald's to boost franchisees as inflation weighs on consumers
-
Outgoing UN chief makes final climate push at New York summit
-
Archaelogical 'breakthrough' could confirm origins of Paris
-
Stocks dip, oil soars despite Trump hailing "productive" Iran talks
-
Fendi brings disco bling, Italian style, to Milan Fashion Week
-
أليكس بودي والبروفيسور الدكتور شتيفان هاوبت يتفقان على التعاون من أجل مجموعة فنية أسطورية في رومانيا
-
アレックス・ボディ氏とシュテファン・ハウプト教授、ルーマニアの伝説的な美術コレクションをめぐり提携に合意
-
Alex Bodi și prof. dr. Stefan Haupt încheie un acord de cooperare pentru o colecție de artă legendară în România
-
Stocks dip, oil rises as traders eye chances of Iran deal
-
Blueberry Strengthens MENA Presence with CMA Category 5 License and Dubai Office Launch
-
Oil falls, stocks steady as Trump hails 'good' Iran talks
-
In first, French presidential candidate gives birth during campaign
-
Canada judge to decide prison term for suicide poison seller
-
A Full Moon for Every Child: STARTRADER's STARCARES Brings Support to SOS Children's Village Ho Chi Minh City
-
Meta leans into AI, smart glasses amid privacy pushback
-
Mongolian herders enlist new tech against harsher, drier climate
-
Oil prices fall after Trump hails 'good' talks with Iran
-
Tata turmoil shines light on India succession woes
-
AI political ads warp reality ahead of US midterms
-
OMP and PwC Alliance Moves Process Manufacturers from Siloed Supply Chain Planning to Unified Decisions
-
Oil prices retreat as markets welcome US-Iran talks
-
Chile's Atacama Desert blossoms with life after El Nino rains
-
French prosecutors probe secret filming of women with smart glasses
-
Drug cocktail killed former child star Hayden Panettiere: coroner
-
Trump renames AI "super intelligence," rejects international oversight
-
Trump rejects international regulation of AI
-
How is the EU approaching record fuel prices?
-
Oil prices slide, AI stock buzz fades
-
11 hurt as teen opens fire outside school in western Turkey
-
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
-
UN chief says 'Big Oil' treats atmosphere as open sewer
-
Tunisia says 2026 summer hottest on record
-
Memoir by Diana's brother goes on sale after rocking UK monarchy
-
Houthis accuse Saudi Arabia of deadly strikes as thousands flee
-
Stocks climb as oil slides, AI buzz returns
-
STARTRADER Expands Its Chinese Equity CFD Range with CXMT and Unitree Robotics
-
MEXC Launches “Real Stocks, Real Friends” with Rewards for Bringing Friends to Wall Street
-
MEXC Expands Opportunity Compass with Stock Trading Handbook to Help Crypto Users Build Investment Knowledge
France to rule on controversial bee-killing pesticide bill
France's top constitutional authority is set on Thursday to rule on the legality of a controversial bill to allow the reintroduction of a pesticide that is harmful to ecosystems but relied on by some European farmers.
The so-called "Duplomb law" has sparked public anger for permitting a return of acetamiprid -- a chemical known to be toxic to pollinators, such as bees, and to the environment.
A student-led petition against the bill garnered more than two million signatures after lawmakers adopted its reintroduction on July 8, when it was rushed through a deeply-divided lower house of parliament without a proper debate.
President Emmanuel Macron has said he is waiting to hear the verdict of the Constitutional Council, which is expected to deliver its ruling on the constitutionality of the law at 6:00 pm (1600 GMT).
If the law is upheld, Macron will have two weeks to enact it or request a second vote in parliament.
Banned in France since 2018, acetamiprid remains legal in the European Union, and proponents say that some French farmers need it to help them compete economically.
The insecticide is particularly sought after by beet and hazelnut growers, who say that they have no alternative against pests and face unfair competition.
But the petition on France's lower-house National Assembly's website, which has garnered more than 2.1 million signatures, calls the measure a "frontal attack on public health".
Beekeepers have described the chemical as "a bee killer", and its effects on humans are also a source of concern, though its risk remains unclear in the absence of large-scale studies.
Left-wing lawmakers, who referred the bill for constitutional review, said it violates France's environmental charter which guarantees the "right to live in a balanced and healthy environment".
For some opponents, frustration stretches beyond environmental and health concerns to exasperation over the country's political deadlock.
One supporter of the petition called it "democratic revenge" after Macron forced a controversial pension reform through parliament in 2023 and dissolved the lower chamber last year, sparking political turmoil that resulted in a hung parliament.
According to a poll published in La Tribune Dimanche in late July, 64 percent of people surveyed hope that Macron will not sign the bill into law but will instead submit it to a new debate in parliament.
In late June, before the law's passage, several thousand demonstrators — including farmers, environmental organisations and scientists -- rallied across France calling for the bill to be withdrawn.
M.Davis--CPN